Skip links

Our strategy

Percheron Therapeutics’ strategy.

We are committed to providing shareholders, potential investors, and the public with a transparent view of our efforts toward fulfilling our purpose: Breakthroughs that change patients’ lives. To that end, our annual reports detail the strategic development, operations, and financial condition of our business.

First

To create antisense drugs for diseases where there are large and/or poorly met markets, in collaboration with Antisense Therapeutics’ technology and research partners.

Second

To advance these drugs successfully through pre-clinical and clnical development via out-sourcing arrangements with expert contractors.

Third

To commercialize the drugs that are shown to be successful in clinical testing by entering into licensing deals or other partnerships with major pharmaceutical companies.